Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 40.14 M34.83 M34.13 M105.75 M36.08 M 210.79 M Research & development ————— — Operating income -53.91 M-19.25 M-11.81 M-97.09 M32.71 M -95.44 M Non-Operating Income, Total 6.32 M6.4 M7.58 M5.59 M4.47 M 24.05 M Interest expense, net of interest capitalized 1.7 M3.65 M10.61 M11.45 M11.19 M 36.9 M Non-Operating Income, excl. Interest Expenses 4.62 M2.75 M-3.03 M-5.86 M-6.44 M -12.58 M Unusual income/expense ————-275 K — Pretax income -73.49 M-29.44 M-21.4 M-109.37 M20.62 M -139.59 M Equity in earnings —-5.56 M-4.81 M-2.63 M-3.95 M -16.95 M Taxes -4.22 M7.12 M-53 M-30.39 M-427 K -76.7 M Non-controlling/minority interest ————— — After tax other income/expense -1.88 M-1.34 M-1.38 M-1.12 M-1.49 M -5.32 M Net income before discontinued operations -69.28 M-36.56 M31.6 M-78.98 M21.04 M -62.9 M Discontinued operations ————— — Net income -69.28 M-36.56 M31.6 M-78.98 M21.04 M -62.9 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -69.28 M-36.56 M31.6 M-78.98 M21.04 M -62.9 M Basic earnings per share (Basic EPS) -1.38-0.70.61-1.510.41 -1.19 Diluted earnings per share (Diluted EPS) -1.38-0.70.61-1.510.41 -1.19 Average basic shares outstanding 50.26 M52.38 M51.58 M51.39 M51 M — Diluted shares outstanding 50.26 M52.38 M51.6 M51.39 M51.06 M — EBITDA 67.65 M150.01 M139.2 M82.15 M179.01 M 550.37 M EBIT -53.91 M-19.25 M-11.81 M-97.09 M32.71 M -95.44 M Cost of revenue 870.3 M912.57 M830.38 M934.48 M879.18 M 3.56 B Other cost of goods sold 870.3 M912.57 M827.47 M934.48 M879.18 M 3.55 B Depreciation & amortization (cash flow) 121.56 M169.26 M151.01 M179.24 M146.29 M 645.81 M